ARIZ Precision Medicine

About:

ARIZ Precision Medicine is a biotechnology company that develops drug candidates for cancer.

Website: https://arizbio.com/

Top Investors: Moneta Ventures, Sacramento Angels

Description:

ARIZ Precision Medicine is a biotechnology company that develops drug candidates for cancer.The acronym stands for a methodology of solving big problems, by breaking the big problem into smaller and smaller problems. This way the company can start at the beginning, the cause of cancer and design drugs that can resolve a specific individual cancer as well as all cancers. ARIZ Precision Medicine uses this methodology to design a specific way to stop the cause of cancer, then target and protect the delivery system and finally, concentrate the drug inside the cancer cell leaving normal cells undamaged.

Total Funding Amount:

$2.67M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Davis, California, United States

Founded Date:

2015-01-01

Contact Email:

brad(AT)arizbio.com

Founders:

Brad Niles, Lonnie Bookbinder

Number of Employees:

11-50

Last Funding Date:

2022-03-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai